126 related articles for article (PubMed ID: 1926656)
1. Characterization of peripheral blood T-cell subpopulation of bladder cancer patients.
Greenstein A; Pecht M; Kaver I; Trainin N; Braf Z
Urol Res; 1991; 19(4):219-22. PubMed ID: 1926656
[TBL] [Abstract][Full Text] [Related]
2. T lymphocyte subsets and function in the peripheral blood of patients with urological cancer.
Kaver I; Pecht M; Trainin N; Greenstein A; Braf Z
Oncology; 1992; 49(2):108-13. PubMed ID: 1574245
[TBL] [Abstract][Full Text] [Related]
3. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. I. PHA-induced lymphocyte transformation.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):336-41. PubMed ID: 429127
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.
Kastelan Z; Lukac J; Derezić D; Pasini J; Kusić Z; Sosić H; Kastelan M
Anticancer Res; 2003; 23(6D):5185-9. PubMed ID: 14981987
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte subsets in urinary bladder carcinoma patients.
Gaafar T; Lotfy M; el Ridi R
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):511-7. PubMed ID: 1726772
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy.
Soygür T; Bedük Y; Baltaci S; Yaman O; Tokgöz G
BJU Int; 1999 Dec; 84(9):1069-72. PubMed ID: 10571638
[TBL] [Abstract][Full Text] [Related]
7. [RBC and T lymphocyte subsets in patients with bladder carcinoma: immunological study].
Xu J; Zhang Y
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):113-6. PubMed ID: 11829798
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma.
Soygür T; Bedük Y; Yaman O; Yilmaz E; Tokgöz G; Gögüş O
Urology; 1999 Jan; 53(1):88-91. PubMed ID: 9886594
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251
[TBL] [Abstract][Full Text] [Related]
10. Regulatory interactions governing the proliferation of T cell subsets stimulated with pokeweed mitogen.
Puck JM; Rich RR
J Immunol; 1984 Mar; 132(3):1106-12. PubMed ID: 6229576
[TBL] [Abstract][Full Text] [Related]
11. Local immune response after intravesical interferon gamma in superficial bladder cancer.
Stavropoulos NE; Ioachim E; Pavlidis N; Pappa L; Kalomiris P; Agnantis NJ
Br J Urol; 1998 Jun; 81(6):875-9. PubMed ID: 9666774
[TBL] [Abstract][Full Text] [Related]
12. Distribution of CD1a-positive Langerhans cells and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections.
Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ
J Pathol; 1995 Dec; 177(4):401-6. PubMed ID: 8568595
[TBL] [Abstract][Full Text] [Related]
13. Studies of the nonspecific cellular immune response in patients with urinary bladder carcinoma. II. Immunodepressive effect of sera from bladder carcinoma.
Nishio S; Horii A; Morikawa Y; Kawakita J; Nishijima T; Kishimoto T; Maekawa M
Invest Urol; 1979 Mar; 16(5):342-5. PubMed ID: 429128
[TBL] [Abstract][Full Text] [Related]
14. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
15. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
Cummings KB; Kodera Y; Bean MA
Natl Cancer Inst Monogr; 1978 Dec; (49):119-22. PubMed ID: 155220
[TBL] [Abstract][Full Text] [Related]
16. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
[TBL] [Abstract][Full Text] [Related]
17. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
18. PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival.
Hou W; Xue M; Shi J; Yang M; Zhong W; Fan X; Zeng H; Lai Y; Huang J; Wang B; Lin T
Urol Oncol; 2020 Aug; 38(8):685.e1-685.e10. PubMed ID: 32409198
[TBL] [Abstract][Full Text] [Related]
19. In vivo depletion of BoT4 (CD4) and of non-T4/T8 lymphocyte subsets in cattle with monoclonal antibodies.
Howard CJ; Sopp P; Parsons KR; Finch J
Eur J Immunol; 1989 Apr; 19(4):757-64. PubMed ID: 2567247
[TBL] [Abstract][Full Text] [Related]
20. A comparison of T4:T8 lymphocyte ratio in the periodontal lesion of healthy and HIV-positive patients.
Steidley KE; Thompson SH; McQuade MJ; Strong SL; Scheidt MJ; Van Dyke TE
J Periodontol; 1992 Sep; 63(9):753-6. PubMed ID: 1361945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
